Business Context and Reporting Period
Company: ALPHA PRO TECH, LTD.
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal year ended December 31, 2001
Business Overview: The Company develops, manufactures, and markets disposable protective apparel, infection control products (masks/shields), extended care products, and consumer goods (pet bedding/toys). Operations are divided into three segments: Apparel, Mask/Shield, and Extended Care. Products are sold primarily in the U.S. to medical, dental, industrial, cleanroom, and food service markets.
Key Financial Metrics
| Metric | 2001 | 2000 |
|---|---|---|
| Sales (Revenue) | $21,333,000 | $21,130,000 |
| Gross Profit | $9,086,000 | $8,892,000 |
| Gross Margin | 42.6% | 42.1% |
| Net Income | $786,000 | $1,460,000 |
| Net Income Per Share (Diluted) | $0.03 | $0.06 |
| Operating Cash Flow | $1,305,000 | $2,091,000 |
| Cash and Equivalents (Year End) | $1,372,000 | $1,131,000 |
| Working Capital | $6,445,000 | $5,815,000 |
| Total Debt (Notes Payable + Capital Leases) | $964,000 | $535,000 |
Material Changes vs. Prior Period
- Revenue Growth: Sales increased 1.0% to $21.33 million. Growth was driven by the Apparel segment (+4.3%), partially offset by declines in Mask/Shield (-2.8%) and Extended Care (-10.1%).
- Profitability Decline: Net income decreased 46.2% to $786,000. This was primarily due to a $647,000 increase in Selling, General, and Administrative (SG&A) expenses and a $71,000 increase in depreciation.
- Operational Restructuring: The Company downsized Mexican operations, closing one facility and reducing staff in another to shift manufacturing to China. This resulted in approximately $134,000 in severance and transition costs.
- External Impact: Sales in the last four months of 2001 were negatively impacted by the September 11th events, which disrupted business and caused an economic downturn.
- Inventory Build-up: Inventories increased by $1.18 million, contributing to a decrease in operating cash flow.
Guidance, Outlook, and Risks
- Outlook: Management expects sales to increase in 2002, marking the seventh consecutive year of growth. Orders booked in early 2002 have returned to normal levels. Gross margins are expected to improve due to increased manufacturing in China.
- Strategy: Focus remains on growing the cleanroom business (via exclusive agreement with VWR Scientific) and expanding in medical, dental, industrial safety, and food service sectors.
- Customer Concentration Risk: The Company is highly dependent on its largest distributor, which accounted for 65.2% of total sales in 2001. The loss of this customer would have a material adverse effect.
- Market Risks: Results could be negatively affected by foreign currency exchange rate fluctuations due to manufacturing in Mexico and China. The Company faces substantial competition from larger entities like Kimberly-Clark and 3M.
- Liquidity: The Company maintains a $4.3 million credit facility with $2.26 million unused as of year-end. Management believes cash flow and credit facilities are sufficient for future needs.
Investor Verification Checklist
- Customer Dependency: Verify the stability of the relationship with the single distributor representing 65.2% of revenue.
- Manufacturing Transition: Assess the success and cost-efficiency of shifting production from Mexico to China.
- SG&A Efficiency: Monitor if SG&A expenses as a percentage of sales decrease in 2002 as management projects.
- Inventory Levels: Review inventory turnover to ensure the $1.18 million increase does not lead to future obsolescence write-downs.
- Post-9/11 Recovery: Confirm that the anticipated sales rebound in 2002 materializes across all segments, particularly Mask/Shield and Extended Care.